..and I think you'll find the move from solid tumours to bloodborne is to show they can deliver through the blood stream to reach more targets. Something I thought you very much wanted them to do some time back. This ties in with the stability of the serum as has been discussed of late. It's joining the dots: enter the cells, add cargo, show it works directly, deliver via injection and target specific cells. If they get all that together, then we know we're on a winner. They are slowly ticking them off step by step, and may be able to get there faster by collaborating.
PYC Price at posting:
1.4¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)